114 related articles for article (PubMed ID: 26480961)
1. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.
Cevher E; Salomon SK; Makrakis A; Li XW; Brocchini S; Alpar HO
J Microencapsul; 2015; 32(8):755-68. PubMed ID: 26480961
[TBL] [Abstract][Full Text] [Related]
2. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies.
Cevher E; Salomon SK; Somavarapu S; Brocchini S; Alpar HO
J Microencapsul; 2015; 32(8):769-83. PubMed ID: 26480962
[TBL] [Abstract][Full Text] [Related]
3. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
4. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
Sayin B; Somavarapu S; Li XW; Sesardic D; Senel S; Alpar OH
Eur J Pharm Sci; 2009 Nov; 38(4):362-9. PubMed ID: 19733658
[TBL] [Abstract][Full Text] [Related]
5. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
6. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
8. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Bento D; Staats HF; Gonçalves T; Borges O
Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
[TBL] [Abstract][Full Text] [Related]
10. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
[TBL] [Abstract][Full Text] [Related]
11. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
[TBL] [Abstract][Full Text] [Related]
13. Trimethyl and carboxymethyl chitosan carriers for bio-active polymer-inorganic nanocomposites.
Geisberger G; Gyenge EB; Maake C; Patzke GR
Carbohydr Polym; 2013 Jan; 91(1):58-67. PubMed ID: 23044105
[TBL] [Abstract][Full Text] [Related]
14. Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.
Sinani G; Sessevmez M; Gök MK; Özgümüş S; Alpar HO; Cevher E
Int J Pharm; 2019 Oct; 569():118592. PubMed ID: 31386881
[TBL] [Abstract][Full Text] [Related]
15. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
17. N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen.
Subbiah R; Ramalingam P; Ramasundaram S; Kim DY; Park K; Ramasamy MK; Choi KJ
Carbohydr Polym; 2012 Aug; 89(4):1289-97. PubMed ID: 24750944
[TBL] [Abstract][Full Text] [Related]
18. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
[TBL] [Abstract][Full Text] [Related]
19. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.
Farhadian A; Dounighi NM; Avadi M
Hum Vaccin Immunother; 2015; 11(12):2811-8. PubMed ID: 26158754
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
